Where it is registered
Each register and historical list with its number of registrations and a few of them.
At a glance
- Registers
- 1
- Registrations
- 13
- With their own page
- 13
- Companies
- 4
All medicines with Conjugated
Human medicines from every register that match Conjugated by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
85 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Conjugated EstrogensCombination | United States | 0.3MG, 0.45MG, 0.625MG … | tablet | Marketed | Novast Labs |
| PremarinCombination | United States | 0.3MG, 0.45MG, 0.625MG … | tablet | Marketed | Wyeth Pharms |
| Premphase 14/14Combination | United States | 0.625MG,0.625MG; 5MG | tablet | Marketed | Wyeth Pharms |
| PremproCombination | United States | 0.3MG; 1.5MG, 0.45MG; 1.5MG, 0.625MG; 2.5MG … | tablet | Marketed | Wyeth Pharms |
| PremarinCombination | United States | 25MG/VIAL | injectable | Marketed | Wyeth Pharms |
| PremarinCombination | United States | 0.625MG/GM | cream | Marketed | Wyeth Pharms |
| Prempro (Premarin;Cycrin)Combination | United States | 0.625MG,0.625MG; 2.5MG,2.5MG | tablet | Not marketed | Wyeth Pharms INC |
| Premphase (Premarin;Cycrin 14/14)Combination | United States | 0.625MG,0.625MG; 5MG | tablet | Not marketed | Wyeth Pharms INC |
| Milprem-200Combination | United States | 0.45MG; 200MG | tablet | Not marketed | Medpointe Pharm HLC |
| Milprem-400Combination | United States | 0.45MG; 400MG | tablet | Not marketed | Medpointe Pharm HLC |
| PMB 200Combination | United States | 0.45MG; 200MG | tablet | Not marketed | Wyeth Ayerst |
| PMB 400Combination | United States | 0.45MG; 400MG | tablet | Not marketed | Wyeth Ayerst |
| DuaveeCombination | United States | 20MG BASE; 0.45MG | tablet | Marketed | Wyeth Pharms |
| Synthetic Conjugated Estrogens ACombination | United States | 0.625MG/GM | cream | Not marketed | Teva Womens |
| Prempro/Premphase | United States | 0.45MG/1.5MG & 0.3MG/1.5MG | Tablet | Marketed | Wyeth Ayerst |
| EnjuviaCombination | United States | 0.3MG, 0.45MG, 0.625MG … | tablet | Not marketed | Aspen |
| CenestinCombination | United States | 0.3MG, 0.45MG, 0.625MG … | tablet | Not marketed | Aspen |
| DuaviveCombination | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Congest | Canada | 0.9 MG | Tablet | Not marketed | Laboratoire Riva INC. |
| Congest | Canada | 2.5 MG | Tablet | Not marketed | Laboratoire Riva INC. |
| Congest | Canada | 0.625 MG | Tablet | Not marketed | Laboratoire Riva INC. |
| Congest | Canada | 1.25 MG | Tablet | Not marketed | Laboratoire Riva INC. |
| Congest | Canada | 0.3 MG | Tablet | Not marketed | Laboratoire Riva INC. |
| Premarin Vaginal Cream | Canada | 0.625 MG / G | Cream | Marketed | Pfizer Canada Ulc |
| DuaviveCombination | Canada | 20 MG + 0.45 MG | Tablet (Immediate- And Extended-Release) | Marketed | Pfizer Canada Ulc |